Status:
COMPLETED
Tiotropium / Respimat One-Year Study
Lead Sponsor:
Boehringer Ingelheim
Conditions:
Pulmonary Disease, Chronic Obstructive
Eligibility:
All Genders
40+ years
Phase:
PHASE3
Brief Summary
To evaluate the long term effects of treatment with two doses of Tiotropium delivered by the Respimat inhaler in patients with COPD.
Eligibility Criteria
Inclusion
Exclusion
Key Trial Info
Start Date :
January 1 2003
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
Estimated Enrollment :
983 Patients enrolled
Trial Details
Trial ID
NCT00168844
Start Date
January 1 2003
Last Update
May 20 2014
Active Locations (72)
Enter a location and click search to find clinical trials sorted by distance.
1
Boehringer Ingelheim Investigational Site
Los Angeles, California, United States
2
Boehringer Ingelheim Investigational Site
Pismo Beach, California, United States
3
Boehringer Ingelheim Investigational Site
San Diego, California, United States
4
Boehringer Ingelheim Investigational Site
Fort Collins, Colorado, United States